Using Twizzlers to screen for gestational diabetes
Official title: Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
Run by Baylor College of Medicine · NCT02610179 · Data updated 2026-11-12
This study is testing if eating 10 Twizzlers can be a good way to check for gestational diabetes in pregnant women, instead of the usual sugary drink.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | Women only |
| Enrollment | 617 (estimated) |
| Sponsor | Baylor College of Medicine Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | April 2015 |
| Main results expected | January 2025 |
| Study ends | March 2027 |
| Registry record updated | May 11, 2023 |
| Trial ID | NCT02610179 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women between 24 to 28 weeks of gestation who are willing to participate.
✕Probably not a fit
Patients with known Type I or Type II diabetes, those on corticosteroids, or those with a previous high glucola screening result will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective trial aims to evaluate the effectiveness of consuming 10 Twizzlers as an alternative to the standard 50 gram glucola beverage for screening gestational diabetes mellitus (GDM) in pregnant women. Participants will be recruited from the Harris Health System Obstetrics Clinics and will have their blood glucose levels measured one hour after consuming the Twizzlers. The study will compare the sensitivity, specificity, and predictive values of the Twizzlers challenge against the glucola beverage, providing insights into a potentially cost-effective screening method for GDM. The trial will also assess the need for follow-up glucose tolerance tests based on the results of the screenings.
Why it matters
Potential benefit: If successful, this study could provide a more palatable and cost-effective method for screening gestational diabetes, improving patient compliance and outcomes.
How similar studies have gone: While the use of alternative screening methods for gestational diabetes is not widely tested, this approach is novel and could provide new insights into effective screening practices.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant * 24 to 28 weeks gestation * Singleton or twin or triplet gestation * Willing to participate in the study Exclusion Criteria: * Known Type II DM * Known Type I DM * On oral or injectable corticosteroids * 50 gram glucola beverage GCT of greater than or equal to 190 mg/dl
Where it's running
-
Ben Taub General Hospital
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Kjersti Aagaard, MD, PhD — Baylor College of Medicine
- Study coordinator: Kjersti Aagaard, MD, PhD
- Email: aagaardt@bcm.edu
- Phone: 713-798-8467
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Islet function in gestational diabetes: see if pancreas changes during and after pregnancy
This study tests whether the human pancreas changes its function during and after pregnancy in people with gestational diabetes or not, using Exendin 9-39 in a small Phase 1 trial.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Home ultrasound in telemedicine care for gestational diabetes (GDM)
This study tests whether using a home ultrasound device at home, guided by a physician, improves satisfaction and outcomes for pregnant people with GDM compared to standard care.
-
Managing cardiometabolic risk in women with gestational diabetes using continuous glucose monitoring and mobile health
This trial will test whether continuous glucose monitoring plus a mobile health lifestyle program helps pregnant women with gestational diabetes control blood sugar and lower cardiometabolic risk for them and their babies.
-
Comparing Metformin and Insulin for Gestational Diabetes Treatment
This study is testing whether metformin is as effective as insulin for treating gestational diabetes in pregnant people and looks at how safe both treatments are for mothers and their babies.
-
Continuous glucose monitoring for pregnant women with gestational diabetes to improve mother and baby outcomes
This project will test whether using continuous glucose monitoring helps pregnant women with gestational diabetes and their babies have better health outcomes than usual monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.